Equity
€435,240 ▲ 38.9%
HDfarma has made a profit in every financial year since 2012.
HDfarma
Lifetime
15 annual accounts with figures on one time axispeak €242,522 (2026)
€242,522▲ 118%
peak €121,927 (2026)
€121,927▲ 274%
peak €435,240 (2026)
€435,240▲ 38.9%
€343,922▲ 0.9%
peak 0.5 FTE (2012)
0.4 FTE▲ 100%
Board2 names since 2022
-
Documentsfilings and deeds
29-09-202632 days before the deadline
2026abbreviated format
Gross margin from €111,055 to €242,522Result from €32,619 to €121,927Staff from 0.2 FTE to 0.4 FTEEquity from €313,313 to €435,240Cash from €197,000 to €428,144
Key points
from the 2026 annual accountsChecked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 34,691 companies had the same profile as HDfarma has now. Each dot stands for 87 companies, two years later.
95.3%
were still trading
3.9%
stopped another way
0.7%
went bankrupt
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 34,691 companies, not a prediction for HDfarma. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0833166058
Changes of role: (director) and (director)
General meeting of 19-12-2023 · Gazette deed
First establishment
Koningin Astridstraat 41, Zedelgem
Incorporation
published on 07-02-2011 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| HDfarma Zedelgem | €779,162 | €242,522 | 55.9% | 0.4 |
| AllGor Kortrijk | €810,045 | €235,538 | 29.2% | 0.6 |
| APOTHEEK DESMEDT MIEKE Zedelgem | €968,003 | €221,683 | 31.1% | 0.8 |
| APOTHEEK VERSYCK AN Knokke-Heist | €860,271 | €258,010 | 41.5% | 0.9 |
| Apotheek Ghesquiere Zonnebeke | €867,740 | €187,592 | 87.4% | 0.8 |
| Apotheek Merkem Houthulst | €785,691 | €178,669 | 88.1% | 0.1 |
| APOTHEEK VERBELEN Kortrijk | €711,358 | €171,996 | 78.0% | 0.6 |
These companies have the same main activity as HDfarma: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €711,000 and €968,000, founded between 2006 and 2011.
Official details
Source: KBO- Status
- Active since 25-01-2011Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730and 1 other
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 31-03-2026
- Establishment unit
- 2.196.144.0398210 Zedelgem, since 01-04-2011
- Financial year end
- 31 March
- Peppol
- Reachable since 27-03-2026
Annual accounts to 31-03-2026
- ≈ €1.1mestimated
- €779,162▲ 19.1%
- Employeeson 31-03-2026
- 1=
- Filing
- Filed on 29-09-2026, 32 days before the end of the filing period
Insights on HDfarma
HDfarma files the abbreviated format. That format states no turnover. The gross margin rose from €120,313 in 2012 to €242,522 in 2026.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about HDfarma
- What is the company number of HDfarma?
- The company number of HDfarma is 0833.166.058. The VAT number is the same number with BE in front: BE 0833.166.058.
- Where is HDfarma based?
- The registered office is at Koningin Astridstraat 41, 8210 Zedelgem.Company details
- What does HDfarma do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of HDfarma?
- HDfarma is a private limited company (BV).
- When was HDfarma founded?
- HDfarma was founded on 25-01-2011.
- Is HDfarma still active?
- Yes, HDfarma is an active enterprise in the KBO register.
- How many employees does HDfarma have?
- HDfarma had an average of 0.4 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
- Which joint committee does HDfarma fall under?
- In its 31-03-2026 annual accounts, HDfarma states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of HDfarma?
- The turnover in financial year 2026 is ≈ €1.1m. This figure is estimated from the gross margin of €242,522 and 51 comparable companies (NACE 477). It probably lies between €760,000 and €2.2m.
- Is HDfarma profitable?
- In financial year 2026, HDfarma made a profit of €121,927.
- Where can I find the annual accounts of HDfarma?
- HDfarma filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
- When are the next annual accounts of HDfarma due?
- HDfarma must file the annual accounts for financial year 2027 by 31-10-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.